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Neutrophilactivityisprolongedinnewborns,suggestingdecreasedexposureand/orresponsestoimmunosuppressivemodulators,
such as 1,25-hydroxyvitamin D3 (1,25-vit D3). We hypothesized that 1,25-vit D3 suppresses neutrophil activation and that
this response is impaired in newborns. Consistent with this, 1,25-vit D3 decreased LPS-induced expression of macrophage
inﬂammatory protein-1β and VEGF in adult, but not neonatal, neutrophils. Expression of vitamin D receptor (VDR) and 25-
hydroxyvitamin D3-1α-hydroxylase was reduced in neonatal, relative to adult neutrophils. Moreover, 1,25-vit D3 induced VDR
gene expression in activated adult, but not neonatal, neutrophils. 1,25-vit D3 also suppressed expression of cyclooxygenase-2 and
induced expression of 5-lipoxygenase in LPS-exposed adult neutrophils, while neonatal cells were not aﬀected. 1,25-vit D3 had
no eﬀect on respiratory burst in either adult or neonatal cells. Anti-inﬂammatory activity of vitamin D is impaired in neonatal
neutrophils, and this may be due to decreased expression of VDR and 1α-hydroxylase. Insensitivity to 1,25-vit D3 may contribute
to chronic inﬂammation in neonates.
1.Introduction
There is a high incidence of vitamin D insuﬃciency in
neonates, particularly those who are exclusively breast fed
[1]. After undergoing 25-hydroxylation in the liver, 25-
hydroxyvitamin D3 is converted, via 25-hydroxyvitamin D3-
1α-hydroxylase (1α-hydroxylase), to the active form 1,25-
vit D3 in many cell types. The biologic eﬀects of 1,25-
vit D3 are primarily mediated via the nuclear transcription
factor, vitamin D receptor (VDR), which triggers expression
of vitamin D-responsive genes. While the importance of
vitamin D in calcium and phosphate homeostasis is well
known, recent studies have demonstrated that vitamin D has
“nonclassical” eﬀects, including an important role in down-
regulating immune responses. VDR and 1α-hydroxylase
are expressed in monocytes, dendritic cells, T-lymphocytes,
and granulocytes, suggesting that 1,25-vit D3 plays a role
in diﬀerentiation, biosynthetic activity, and function of
leukocytes [2, 3].
Circulating neutrophils are the main eﬀector cells in
innate immunity but can contribute to pathology if their
activity is prolonged [4, 5]. Resolution of the neutrophilic
inﬂammatory response is an active process involving down-
regulation of proinﬂammatory cytokines, upregulation of
anti-inﬂammatory eicosanoids, decreased generation of
reactive oxygen intermediates, and removal of the cells [6].
In this regard, we have previously shown that the clearance
of neutrophils by apoptosis is impaired in neonates when
compared to adults [7]. Prolonged viability of neonatal
neutrophils is thought to play a role in chronic inﬂammatory
diseasebecausethesecellsreleaseoxygenradicals,hydrolases,
and inﬂammatory cytokines. This results in cytotoxicity,
potentially contributing to the high incidence of neutrophil-
mediated inﬂammatory diseases in newborns.
Previous studies have suggested that vitamin D downreg-
ulates neutrophil function [8]. In these studies, we investi-
gated the hypothesis that 1,25-vit D3 decreases production of
inﬂammatory mediators and reactive oxygen intermediates
in neutrophils and that this activity is impaired in neonatal
neutrophils. We further hypothesized that reduced responses
in neonates may be related to decreased expression of
VDR and 1α-hydroxylase in neonatal neutrophils. Impaired2 Mediators of Inﬂammation
responsiveness to 1,25-vit D3 may contribute to prolonged
viability and activity of these cells, leading to increased
susceptibility to chronic inﬂammatory diseases.
2.MaterialsandMethods
2.1. Reagents. RNA puriﬁcation kits were purchased from
Qiagen (Chatsworth, CA). Primers for RT-PCR were
obtainedfromIntegratedDNATechnologies(Coralville,IA).
Reagents for RT-PCR were from Applied Biosystems (Foster
City, CA). Amplex Red and horseradish peroxidase were
from Molecular Probes (Carlsbad, CA), DMEM and dextran
from Sigma Chemical Co. (St. Louis, MO), and Ficoll-paque
from GE Healthcare (Piscataway, NJ). 7-actinomycin D (7-
AAD) and cytometric bead array ﬂex sets were from BD
Biosciences (San Jose, CA). 1,25-vit D3 was obtained from
Enzo Life Sciences (Plymouth Meeting, PA) and solubilized
in ethanol at a stock concentration of 10−4M. The ﬁnal
concentration of 10−7Mi nc e l lc u l t u r ew a sb a s e do n
estimates of tissue concentrations and on previous studies
demonstrating biologic eﬀects at this concentration [8].
2.2. Subjects and Neutrophil Isolation. Studies were approved
by the Institutional Review Board of Robert Wood Johnson
Medical School and informed consent obtained from sub-
jects. Umbilical cord blood was obtained from the placentas
of term infants (≥37wk gestation, n = 27) delivered by
cesarean section without labor. Peripheral venous blood
collected from healthy adults (n = 25) was used for compari-
son. Neonatal and adult samples were anticoagulated using
heparin and processed immediately in parallel. Subjects
were excluded for clinical evidence of infection, history of
immunodeﬁciency, diabetes, pregnancy-induced hyperten-
sion, or exposure to tobacco or to medications that aﬀect
immune function. While subjects were also to be excluded
if there was recent history of vitamin D intoxication (due to
unusual dietary supplementation) or deﬁciency (diagnosed
secondary to neonatal hypocalcemia), no prospective sub-
jects met these criteria. Equivalent numbers of adult and
neonatal samples were collected concurrently and uniformly
throughout a single year, to minimize any potential seasonal
eﬀects. Neutrophils were isolated by dextran sedimentation
and Ficoll gradient centrifugation, with >95% viability
and purity conﬁrmed by trypan staining. In preliminary
experiments,1,25-vitD3 didnotaﬀectneutrophilviabilityor
apoptosis, as determined by ﬂow cytometric measurementof
propidium iodide or annexin V binding, respectively.
2.3. Analysis of mRNA Expression. Neutrophils were incu-
bated with control medium (DMEM + 10% fetal bovine
serum), bacterial lipopolysaccharide (LPS, 1 μg/mL), and/or
1,25-vit D3 (10−7M) for 4hr. LPS was used as an inﬂamma-
tory stimulus because of the diverse CD14/TLR4-mediated
responses that have been demonstrated in neutrophils.
RNA was isolated using a RNeasy Minikit (Qiagen) and
cDNA synthesized using a reverse transcription kit (Applied
Biosystems, Foster City, CA). Real time PCR was performed
using SYBR Green PCR Master Mix and ampliﬁed on an
ABI Prism 7900 sequence detection system, using GAPDH
as a standard. Full-length coding sequences for genes to
be analyzed were obtained from GenBank. Primers were
designed using Primer Express software and synthesized by
Integrated DNA Technologies (Coralville, IA). The following
primers were used: VDR: 5 -TCC CTG TCA CCA AGC
TCA CA-3 ;5  -CAA CCA ACC CCT TAG ACC CAG-3 ;1 α-
hydroxylase: 5 -AGA CAT CCC AGG CCC CTC TA-3 ;5  -
TTG CAG AAA AGT TCG GCC A-3 . 5-lipoxygenase (5-
LOX): 5 -AGG GAG AAG CTG TCC GAG T-3 ;5  -GCA
GAG GCC GTG AAG ATC AC-3 ; cyclooxygenase-2 (COX-
2): 5 -GCC TGA TGA TTG CCC GAC T-3 ;5  -GCT GGC
CCT CGC TTA TGA TCT-3 .
2.4.InﬂammatoryProteins. Neutrophilswereincubatedwith
control medium (DMEM + 10% fetal bovine serum),
LPS (1μg/mL), and/or 1,25-vit D3 (10−7M) for 24hr.
Culture supernatants were incubated with premixed ﬂex set
beads coated with antibodies to macrophage inﬂammatory
protein-1β (MIP-1β), IL-8, vascular endothelial growth fac-
tor (VEGF), and IL-1β in 96-well ﬁltration plates. Premixed
phycoerythrin-labeled detection reagent was then added to
thewellsandincubatedinthedarkfor2hr.Thebead-protein
complexes were analyzed for ﬂuorescence intensity using a
BD FACSArray Bioanalyzer. Data were analyzed using BD
FCAP software (v 2.0).
2.5. Measurement of Hydrogen Peroxide (H2O2) Production.
Neutrophils were plated in 96-well dishes (5 × 104cells/well).
A reaction mixture (50μL) containing Amplex Red (25μM)
and horseradish peroxidase (1.07U/mL) was added to each
well, followed by the inﬂammatory stimulus, phorbol 12-
myristate 13-acetate (PMA, 500nM), 1,25-vit D3 (10−7M),
1,25-vit-D3 +PMA,ormediumcontrol.Fluorescentproduct
formation, indicative of H2O2, was measured spectrophoto-
metrically at 1min intervals for 30min at 540nm excitation
and 590nm emission on a Perkin Elmer HTS 7000 Bio Assay
Reader [9].
2.6. Data Analysis. Comparison of cytokine levels and
mRNA expression in neonates and adults was performed
using the Wald-Wolfowitz Runs Test. In order to compare
the values for treatments in same subjects, analyses for
dependent measures were calculated using the Wilcoxon
Matched Pairs Test. To compare multiple dependent samples
d e r i v e df r o mr e p e a t e dm e a s u r e so fH 2O2 levels over time
(0, 10, 20, and 30min), we performed Friedman ANOVA.
These analyses were performed for each treatment condition
in newborns and adults. Within-subject comparisons of
treatment with PMA and PMA + 1,25-vit D3 at speciﬁed
time points were performed using Wilcoxon Matched Pairs
Tests. H2O2 generation by neonatal and adult neutrophils
was compared using the Mann-Whitney U test.
3. Results and Discussion
In order to model bacterial-induced tissue inﬂammation, we
analyzed the responses of LPS-treated adult and neonatalMediators of Inﬂammation 3
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Figure 1: Eﬀects of LPS and 1, 25-vit D3 on expression of VDR, 1-α hydroxylase, COX-2, and 5-LOX in neutrophils. Adult (black column)
and neonatal (grey column) neutrophils were incubated with LPS (1μg/mL) and/or 1,25-Vit D3(10−7M ) ,o rm e d i u mc o n t r o lf o r4h .m R N A
expression of the (a) VDR, (b) 1-α hydroxylase, (c) COX-2, and (d) 5-LOX. Results were normalized to GAPDH expression. Each bar
represents the mean ± SE (n = 7–11). ∗Signiﬁcantly diﬀerent (P<0.05) from LPS; ∗∗signiﬁcantly diﬀerent (P<0.05) from control;
†signiﬁcantly diﬀerent (P<0.05) from adult.
neutrophilsto1,25-vitD3.Ininitialstudies,wecomparedthe
eﬀects of 1,25-vit-D3, LPS, and LPS + 1,25-vit D3 on mRNA
expression of genes involved in vitamin D metabolism and
inﬂammation. Constitutive mRNA expression of VDR, 1-α-
hydroxylase, 5-LOX, and COX-2 was decreased in neonatal,
when compared to adult neutrophils (Figure 1). While 1,25-
vit D3 or LPS alone did not signiﬁcantly aﬀect expression of
these genes in either adult or neonatal cells, treatment with
LPS + 1,25-vit D3 was associated with a signiﬁcant induction
ofVDRinadultcellswhencomparedtocontrolorLPSalone.
1-α-hydroxylase expression was also increased in adult cells
after exposure to LPS + 1,25-vit D3. In contrast, LPS + 1,25-
vit D3 did not aﬀect expression of VDR or 1-α-hydroxylase
in neonatal neutrophils. In addition, 1,25-vit D3 induced 5-
LOX and inhibited COX-2 gene expression in LPS-treated
adult cells, while neonatal cells were not aﬀected.
In further studies, we compared the eﬀects of 1,25-
vit D3, LPS, and LPS + 1,25-vit D3 on the production of
inﬂammatory cytokines and proteins by adult and neonatal
neutrophils.ConstitutiveproductionofMIP-1β,IL -8,VEGF ,
and IL-1β was similar in adult and neonatal neutrophils
(Figure 2). LPS induced production of MIP-1β,I L - 8 ,a n d
IL-1β adult cells, while neonatal cells were not aﬀected. In
adult neutrophils, LPS + 1,25-vit D3 signiﬁcantly inhibited
the generation of MIP-1β a n dV E G Fw h e nc o m p a r e dt oL P S
alone, and there was a trend toward decreased production
of IL-8. In contrast, 1,25-vit D3 did not signiﬁcantly aﬀect
production of these inﬂammatory proteins in LPS-treated
neonatal neutrophils.
We next compared the eﬀects of 1,25-vit D3 on produc-
tion of H2O2 in adult and neonatal neutrophils. Activated
neutrophilssecretereactiveoxygenintermediatesinresponse4 Mediators of Inﬂammation
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Figure 2: Eﬀects of MEHP on inﬂammatory mediator production. Adult (black column) and neonatal (grey column) neutrophils were
incubated in the presence or absence of LPS (1μg/mL) and/or 1,25-Vit D3(10−7M) for 24h. The inﬂammatory mediators (a) MIP-1β,( b )
IL-8, (c) VEGF, and (d) IL-1β were measured in culture supernatants using cytometric bead array analysis. Each bar represents the mean ±
SE (n = 4–11). ∗Signiﬁcantly diﬀerent (P<0.05) from LPS; ∗∗signiﬁcantly diﬀerent (P<0.05) from control.
to inﬂammatory mediators at sites of infection or tissue
injury.Intheabsenceofstimulation,bothadultandneonatal
cellsgenerateddetectiblebasalquantitiesofH2O2 (Figure 3).
Consistent with previous studies, production of H2O2 in
activated neutrophils was decreased in neutrophils from
neonates, when compared to adults [10]. 1,25-vit D3 alone
did not aﬀect H2O2 production in either adult or neonatal
cells.Theinﬂammatorystimulant,PMA,inducedrespiratory
burst activity in both adult and neonatal cells, but this
response was less robust in neonatal cells. 1,25-vit D3 did
not signiﬁcantly aﬀect PMA-stimulated H2O2 generation in
either adult or neonatal neutrophils.
In these studies, we demonstrated that 1,25-vit D3
decreases speciﬁc inﬂammatory responses in mature cir-
culating neutrophils and that this is impaired in neonatal
cells. Previous ﬁndings on the eﬀects of vitamin D on
neutrophils have been inconsistent. For example, vitamin
D induces expression of human cathelicidin antimicrobial
peptide 18 [11], and vitamin D deﬁciency decreases TLR-
induced cathelicidin expression in monocytes [12]. There-
fore, vitamin D appears to play an important role in the
integrity of the innate immune response. However, vitamin
D also decreases production of IL-1β in neutrophils [8],
and increasing evidence suggests that vitamin D can trigger
resolution of inﬂammatory responses. 1,25-vit D3 inhibits
diﬀerentiation, proliferation, and synthetic activity in T
lymphocytes and induces a tolerogenic state in dendritic
cells, suggesting that it suppresses adaptive immunity [13,
14]. While 1,25-vit D3 may promote diﬀerentiation and
synthetic activity in monocytes and macrophages [15, 16],
it also decreases proliferation and interleukin-2 production
and inhibits production of IL-12 by downregulating NF-
κB activation in these cells [17, 18]. It also downregulates
Toll-like receptor-(TLR-)2 and TLR-4 expression in humanMediators of Inﬂammation 5
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Figure 3: 1,25 vit D3 does not suppress PMA-induced H2O2 generation in adult or neonatal neutrophils. Adult (a) and neonatal (b)
neutrophils (5 × 104 cells) were incubated with Amplex Red (25μM) and horseradish peroxidise and then treated with PMA (500nM)
or medium control, in the presence or absence of 1,25-vit D3(10−7 M). H2O2 production was quantiﬁed at 1min intervals for 30min. Each
point represents the mean ± SE (n = 6). Control, ;P M A , ; 1,25-Vit D3, ; PMA + 1,25-Vit D3, .
monocytes [19]. Our ﬁndings that 1,25-vit D3 decreases
neutrophil activity support the idea that vitamin D plays a
physiologic role in the suppression of immune responses.
Neonates are at particularly high risk for developing
neutrophil-mediated inﬂammatory diseases, suggesting that
there are developmental defects in signaling pathways that
down regulate neutrophil activity and induce their clearance
by macrophages. Consistent with this idea, our labora-
tory has previously shown that apoptosis is impaired in
neutrophils from neonates when compared to adults [7].
In these studies, we have shown that responsiveness to
vitamin D is also impaired in neonatal neutrophils. This
may contribute to prolonged viability and activity of these
cells, possibly contributing to chronic inﬂammatory disease
secondary to the release of reactive oxygen species and
inﬂammatory cytokines. Decreased responsiveness may be
due to reduced expression of VDR. We found that adult
neutrophils express VDR and that 1,25-vit D3 induces VDR
expression in the presence of LPS. Induction of VDR by
1,25-vit D3 and LPS has also been observed previously in
a human monocytic cell line [20]. In contrast, neonates
expressed signiﬁcantly lower levels of VDR, and this was not
aﬀectedbyvitaminDandLPS.Wealsofoundthatexpression
of 1α-hydroxylase is signiﬁcantly decreased in neonatal
neutrophils, when compared to adults. 1α-hydroxylase is
required for the generation of 1,25-vit D3, the biologically
active form that triggers binding to response elements in the
promoter regions of vitamin D responsive genes. Decreased
expression of this enzyme suggests that activation of vitamin
D may be impaired in neonatal leukocytes. In addition,
1,25-vit D3 induced 5-LOX and suppressed COX-2 gene
expression in LPS-treated adult neutrophils, while neonatal
cells were not aﬀected. 5-LOX catalyzes the generation of
anti-inﬂammatory eicosanoids such as lipoxins, while COX-
2 exerts inﬂammatory eﬀects via synthesis of prostaglandins
[21]. The shift from generation of pro- to anti-inﬂammatory
eicosanoids is thought to play a key role in signaling the
resolution of neutrophil activity [22]. Impaired alteration
of the ratio of 5-LOX/COX-2 gene expression in response
to vitamin D may contribute to prolonged inﬂammation in
neonates.
Previous in vitro and in vivo studies in humans have
suggestedthatvitaminDisassociatedwithdecreasedinﬂam-
matory cytokine production [8, 23]. To our knowledge, this
is the ﬁrst study to measure cytokine responses to vitamin
D in neonatal neutrophils. We found that while vitamin D
suppressed LPS-induced production of MIP-1β and VEGF
in adult cells, it had no eﬀect on the production of these
mediators in neonatal cells. This is consistent with our
ﬁnding that expression of VDR is impaired in neonatal
neutrophils. Taken together, these data suggest that neonatal
neutrophils have decreased capacity to synthesize 1,25-vit
D3 and decreased responsiveness to its immunosuppressive
eﬀects.
Surprisingly, vitamin D did not reduce basal or PMA-
induced generation of hydrogen peroxide in either adult or
neonatal neutrophils. Consistent with this, previous inves-
tigators have reported that vitamin D restores chemotaxis
and phagocytosis in vitamin D-deﬁcient mice [24]a n d
can facilitate bacterial killing in human cells [25]. Others
have also shown that vitamin D induces expression of
membrane and cytosolic components of NADPH-oxidase in6 Mediators of Inﬂammation
monocyte-like cell lines [26]. The eﬀects of vitamin D on
respiratory burst activity are likely dependent on speciﬁcs of
dose and endpoint, and this will be investigated in further
studies.
4. Conclusions
Wefoundthat1,25-vitD3 decreasedLPS-inducedexpression
of macrophage inﬂammatory protein-1β a n dV E G Fi na d u l t ,
but not neonatal, neutrophils. Our ﬁndings suggest that
neonates may be resistant to the modulatory eﬀects of
vitamin D in neutrophilic inﬂammation and that this may
be due to decreased expression of VDR and 1α-hydroxylase.
Decreased responsiveness to vitamin D in neonates may
compound the eﬀects of vitamin D deﬁciency, which is
now recognized as an important public health problem.
Investigations of vitamin D status have revealed a high
incidence of deﬁciency in both mothers and infants [26],
and the American Academy of Pediatrics recently issued rec-
ommendations for increased dietary supplementation with
vitamin D in neonates [27]. Understanding the immune-
modulatory actions of vitamin D in neonates at the cellular
level may strengthen eﬀorts to adequately address this public
health challenge, using strategies such as therapeutic levels of
supplementation or treatment with synthetic VDR agonists.
Abbreviation
1α-hydroxylase: 25-hydroxyvitamin D3-1α-hydroxylase
COX-2: Cyclooxygenase-2
5-LOX: 5-lipoxygenase
LPS: Bacterial lipopolysaccharide
MIP-1β: Macrophage inﬂammatory protein-1β
PMA: Phorbol 12-myristate 13-acetate
VEGF: Vascular endothelial growth factor
VDR: Vitamin D receptor
1,25-vit D3: 1,25-dihydroxycholecalciferol.
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